| Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages JL Guerriero, A Sotayo, HE Ponichtera, JA Castrillon, AL Pourzia, ... Nature 543 (7645), 428-432, 2017 | 539 | 2017 |
| Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer J Hu, SS Hwang, M Liesa, B Gan, E Sahin, M Jaskelioff, Z Ding, H Ying, ... Cell 148 (4), 651-663, 2012 | 353 | 2012 |
| CDK12 inhibition reverses de novo and acquired PARP inhibitor resistance in BRCA wild-type and mutated models of triple-negative breast cancer SF Johnson, C Cruz, AK Greifenberg, S Dust, DG Stover, D Chi, ... Cell reports 17 (9), 2367-2381, 2016 | 288 | 2016 |
| Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance N Johnson, SF Johnson, W Yao, YC Li, YE Choi, AJ Bernhardy, Y Wang, ... Proceedings of the National Academy of Sciences 110 (42), 17041-17046, 2013 | 273 | 2013 |
| The BRCA1-Δ11q alternative splice isoform bypasses germline mutations and promotes therapeutic resistance to PARP inhibition and cisplatin Y Wang, AJ Bernhardy, C Cruz, JJ Krais, J Nacson, E Nicolas, S Peri, ... Cancer research 76 (9), 2778-2790, 2016 | 261 | 2016 |
| Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer AK Mehta, EM Cheney, CA Hartl, C Pantelidou, M Oliwa, JA Castrillon, ... Nature cancer 2 (1), 66-82, 2021 | 183 | 2021 |
| Financial toxicity in cancer care: origins, impact, and solutions HR Abrams, S Durbin, CX Huang, SF Johnson, RK Nayak, GJ Zahner, ... Translational behavioral medicine 11 (11), 2043-2054, 2021 | 143 | 2021 |
| Association between racial and ethnic diversity in medical specialties and residency application rates MJN Tiako, S Johnson, M Muhammad, NY Osman, SR Solomon JAMA Network Open 5 (11), e2240817-e2240817, 2022 | 52 | 2022 |
| Normalizing service learning in medical education to sustain medical student-led initiatives MJN Tiako, SF Johnson, NT Nkinsi, A Landry Academic Medicine 96 (12), 1634-1637, 2021 | 22 | 2021 |
| The Metastatic Breast Cancer (MBC) project: Accelerating translational research through direct patient engagement. N Wagle, C Painter, E Anastasio, M Dunphy, M McGillicuddy, D Kim, ... Journal of Clinical Oncology 35 (15_suppl), 1076-1076, 2017 | 21 | 2017 |
| Disparities in the recovery from critical illness due to COVID-19 SF Johnson, MJN Tiako, MJE Flash, DJ Lamas, GA Alba The lancet. Psychiatry 7 (8), e54, 2020 | 20 | 2020 |
| Sensitizing HR-proficient cancers to PARP inhibitors E Lim, SF Johnson, M Geyer, V Serra, GI Shapiro Molecular & cellular oncology 4 (6), e1299272, 2017 | 9 | 2017 |
| Disparities in post-intensive care syndrome during the COVID-19 pandemic: challenges and solutions MJE Flash, SF Johnson, MJ Nguemeni Tiako, A Tan-McGrory, ... NEJM Catalyst Innovations in Care Delivery 1 (6), 2020 | 8 | 2020 |
| Restricted stock versus other sources of managerial incentives D Chi, S Johnson Unpublished working paper, Arizona State University, Tempe, AZ, 2007 | 7 | 2007 |
| Academic Health Centers' Antiracism Strategies Must Extend to Their Business Practices SF Johnson, A Ojo, HJ Warraich Annals of Internal Medicine 174 (2), 254-255, 2021 | 6 | 2021 |
| The CDK inhibitor dinaciclib sensitizes triple-negative breast cancer cells to PARP inhibition. SF Johnson, N Johnson, D Chi, B Primack, AD D'Andrea, E Lim, ... Cancer Research 73 (8_Supplement), 1788-1788, 2013 | 4 | 2013 |
| The Metastatic Breast Cancer Project: Partnering with patients to accelerate progress in cancer research N Wagle, C Painter, E Anastasio, M Dunphy, M McGillicuddy, R Stoddard, ... Cancer Research 78 (13_Supplement), 5371-5371, 2018 | 3 | 2018 |
| A student-led interprofessional virtual outreach program for people with HIV during the Covid-19 pandemic: a pilot program at an academic medical center in Boston DA Solomon, S Larrabee, J Ellis, P Erfani, SF Johnson, KM Rich, ... BMC Medical Education 22 (1), 657, 2022 | 2 | 2022 |
| 238 Reversal of primary and acquired PARP-inhibitor resistance in BRCA-mutated triple-negative breast cancers by inhibition of transcriptional cyclin-dependent kinases (CDKs) S Johnson, N Johnson, D Chi, B Primack, C Cruz, D Stover, ... European Journal of Cancer 50, 80, 2014 | 1 | 2014 |
| A high-touch outreach model to re-engage patients in mammogram screening. A Ojo, S Johnson, P Erfani, R Guo, A Garmilla, A Saini, B Benitez, ... Journal of Clinical Oncology 40 (16_suppl), e18555-e18555, 2022 | | 2022 |
